Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/5049| Title: | Trastuzumabe e pertuzumabe versus acomentimento visceral |
| Authors: | INCA Instituto Nacional de Câncer (Brasil) Instituto Nacional de Câncer José Alencar Gomes da Silva Sistema Único de Saúde (Brasil) Brasil. Ministério da Saúde |
| Keywords: | Trastuzumab Trastuzumab Neoplasias de la Mama/tratamiento farmacológico Neoplasias da Mama/tratamento farmacológico Breast Neoplasms/drug therapy |
| Issue Date: | Dec-2021 |
| Publisher: | INCA |
| Series/Report no.: | Ano V, n. 55. |
| Description: | 2 p. |
| URI: | http://sr-vmlxaph03:8080/jspui/handle/123456789/5049 |
| Appears in Collections: | Informe SUS - ONCO 2021 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Dezembro_2021 (3).pdf | 482.91 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.